This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BRANFORD, Conn., Jan. 10, 2011 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that Matthew J. Herwig has joined the executive management team as Vice President of Sales and Marketing.
Mr. Herwig was most recently Vice President of U.S. Marketing for Energy Based Devices at Covidien Healthcare (formerly Tyco Healthcare), a leading global healthcare products company. He had previously held the positions of Director of Global Marketing – Imaging Solutions/Pharmaceuticals, Director of U.S. Marketing – Imaging Solutions, Vice President of Marketing and Sales Training – Nellcor, all during his tenure at Covidien. Prior to those senior leadership positions, Mr. Herwig held various marketing and sales positions for Mallinckrodt, which was purchased by Covidien Healthcare. In addition he worked for Computerized Medical Systems, an Elekta Company, where he was the Vice President of Marketing and North America Sales, and Ethicon, Inc., a Johnson & Johnson Company.
Thomas M. Patton, President and CEO of CASMED, stated, "Matt is a terrific addition to our management team, bringing valuable experience in strategic planning, global marketing and sales execution. This is an exciting time for the Company as we capitalize on our technological advantages in the areas of tissue oximetry and non-invasive blood pressure. Matt's commercial skills should help our products gain greater recognition and penetration in the marketplace."
Mr. Herwig is a graduate of Southeast Missouri State University, and is a candidate for an M.B.A. at Webster University. His employment with CASMED commenced January 7, 2011.
About CASMED ® - Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter is the first cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.